Comparison of the Treatment of Refractory Bladder Pain Syndrome With Dimethyl Sulfoxide (DMSO) Alone and DMSO as a Carrier Molecule for Botulinum Toxin A Instillation.

Trial Profile

Comparison of the Treatment of Refractory Bladder Pain Syndrome With Dimethyl Sulfoxide (DMSO) Alone and DMSO as a Carrier Molecule for Botulinum Toxin A Instillation.

Completed
Phase of Trial: Phase 0

Latest Information Update: 13 Jun 2017

At a glance

  • Drugs Botulinum toxin A (Primary) ; Dimethyl sulfoxide
  • Indications Bladder disorders; Interstitial cystitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 08 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 07 Apr 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top